
Koosha Sharifi-tafreshi
Examiner (ID: 427, Phone: (571)270-5897 , Office: P/2623 )
| Most Active Art Unit | 2623 |
| Art Unit(s) | 2623, 2628, 2629, 2695 |
| Total Applications | 1252 |
| Issued Applications | 995 |
| Pending Applications | 71 |
| Abandoned Applications | 217 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14129955
[patent_doc_number] => 20190099367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => CHEWABLE DOSAGE FORMS CONTAINING SITAGLIPTIN AND METFORMIN
[patent_app_type] => utility
[patent_app_number] => 16/141495
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141495
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141495 | Chewable dosage forms containing sitagliptin and metformin | Sep 24, 2018 | Issued |
Array
(
[id] => 16304124
[patent_doc_number] => 10772895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 16/137493
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12807
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137493
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/137493 | Pharmaceutical composition | Sep 19, 2018 | Issued |
Array
(
[id] => 16025723
[patent_doc_number] => 10675261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Methods and compositions to inhibit dependence on opioids
[patent_app_type] => utility
[patent_app_number] => 16/133458
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3868
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133458 | Methods and compositions to inhibit dependence on opioids | Sep 16, 2018 | Issued |
Array
(
[id] => 13774577
[patent_doc_number] => 20190000827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/109458
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109458 | COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES | Aug 21, 2018 | Abandoned |
Array
(
[id] => 13774579
[patent_doc_number] => 20190000828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/109463
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109463 | COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES | Aug 21, 2018 | Abandoned |
Array
(
[id] => 13603805
[patent_doc_number] => 20180353451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => BROMFENAC BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 16/107174
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/107174 | BROMFENAC BIOAVAILABILITY | Aug 20, 2018 | Abandoned |
Array
(
[id] => 14069139
[patent_doc_number] => 20190083457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS FOR PROTECTING, EXPANDING AND INCREASING THE POTENCY OF HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/104694
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104694
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/104694 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS FOR PROTECTING, EXPANDING AND INCREASING THE POTENCY OF HEMATOPOIETIC STEM CELLS | Aug 16, 2018 | Abandoned |
Array
(
[id] => 15492973
[patent_doc_number] => 20200046675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Cannabinoid Formulation Packaged in a Glass Vial For Pulmonary Delivery
[patent_app_type] => utility
[patent_app_number] => 16/102286
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/102286 | Cannabinoid Formulation Packaged in a Glass Vial For Pulmonary Delivery | Aug 12, 2018 | Abandoned |
Array
(
[id] => 16236725
[patent_doc_number] => 20200253959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/637590
[patent_app_country] => US
[patent_app_date] => 2018-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637590 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES | Aug 7, 2018 | Abandoned |
Array
(
[id] => 14040555
[patent_doc_number] => 20190076384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => METHODS FOR TREATING UREA CYCLE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/057335
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16057335
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/057335 | METHODS FOR TREATING UREA CYCLE DISORDERS | Aug 6, 2018 | Abandoned |
Array
(
[id] => 16769719
[patent_doc_number] => 10980802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Medicament for treating mental and behavioural disorders
[patent_app_type] => utility
[patent_app_number] => 16/043219
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6639
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16043219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/043219 | Medicament for treating mental and behavioural disorders | Jul 23, 2018 | Issued |
Array
(
[id] => 13618481
[patent_doc_number] => 20180360792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => Method of Treatment of Alopecia with Monoterpenoids
[patent_app_type] => utility
[patent_app_number] => 16/040360
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16040360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/040360 | Method of Treatment of Alopecia with Monoterpenoids | Jul 18, 2018 | Abandoned |
Array
(
[id] => 18186352
[patent_doc_number] => 11576910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Methods of treating heart failure with cardiac sarcomere activators
[patent_app_type] => utility
[patent_app_number] => 16/625958
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 23686
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625958
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625958 | Methods of treating heart failure with cardiac sarcomere activators | Jun 28, 2018 | Issued |
Array
(
[id] => 13488599
[patent_doc_number] => 20180295842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Anthroquinone Containing Derivatives as Biochemical Agricultural Products
[patent_app_type] => utility
[patent_app_number] => 15/995437
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15995437
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/995437 | Anthroquinone containing derivatives as biochemical agricultural products | May 31, 2018 | Issued |
Array
(
[id] => 15618737
[patent_doc_number] => 20200079773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => CARBOXYLIC ACID DERIVATIVES OF PYRIDOQUINAZOLINES USEFUL AS PROTEIN KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/616577
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616577 | CARBOXYLIC ACID DERIVATIVES OF PYRIDOQUINAZOLINES USEFUL AS PROTEIN KINASE INHIBITORS | May 30, 2018 | Abandoned |
Array
(
[id] => 13443915
[patent_doc_number] => 20180273500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE
[patent_app_type] => utility
[patent_app_number] => 15/994626
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994626 | TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE | May 30, 2018 | Abandoned |
Array
(
[id] => 14132205
[patent_doc_number] => 20190100492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => TREATMENT FOR LIPODYSTROPHY
[patent_app_type] => utility
[patent_app_number] => 15/992957
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992957
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/992957 | TREATMENT FOR LIPODYSTROPHY | May 29, 2018 | Abandoned |
Array
(
[id] => 15797065
[patent_doc_number] => 20200121675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => A TOPICAL COMPOSITION FOR TREATING ROSACEA AND A METHOD FOR TREATING ROSACEA WITH THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/616444
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616444 | Topical composition for treating rosacea and a method for treating rosacea with the same | May 24, 2018 | Issued |
Array
(
[id] => 15930979
[patent_doc_number] => 20200157123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PENICILLIN-BINDING PROTEIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/616294
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616294
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616294 | Penicillin-binding protein inhibitors | May 24, 2018 | Issued |
Array
(
[id] => 15862851
[patent_doc_number] => 20200138829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => METHODS OF CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/616384
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616384 | METHODS OF CANCER TREATMENT | May 23, 2018 | Abandoned |